Variable | Univariate analysis | multivariate analysis | |||
---|---|---|---|---|---|
No. | χ2 | P | HR((95%CI) | P | |
Gender | |||||
 Male | 67 | 1.689 | .194 |  |  |
 Female | 16 |  |  | .584(.170–2.008) | .394 |
Age | |||||
 ≥ 63 years | 43 | 1.782 | .182 |  |  |
 <63 year | 40 |  |  | 2.345 (1.068–5.147) | .034 |
Primary tumor location | |||||
 Cervix+Upper thorax | 6 | 2.061 | .357 |  |  |
 Middle thorax | 36 |  |  |  |  |
 Lower thorax | 41 |  |  |  |  |
Radical surgery | |||||
 Ivor-Lewis surgery | 48 | .385 | .535 |  |  |
 Sweet surgery | 26 |  |  |  |  |
pT | |||||
 pT1 + 2 | 35 | .036 | .850 |  |  |
 pT3 + 4 | 48 |  |  |  |  |
pN | |||||
 pN0 | 40 | 1.769 | .184 |  |  |
 pN+ | 43 |  |  | 1.339(.622–2.879) | .456 |
pStagea(AJCC 7th edition) | |||||
 I + II | 49 | 1.456 | .228 |  |  |
 III | 34 |  |  |  |  |
Interval to recurrence | |||||
 >6 months | 20 | .001 | .980 |  |  |
 ≤ 6 months | 63 |  |  |  |  |
Recurrent lymph node size | |||||
 >5.5 cm3 | 41 | 1.146 | .284 |  |  |
 ≤ 5.5 cm3 | 42 |  |  |  |  |
Number of recurrent nodes | |||||
 Multiple | 64 | .607 | .436 |  |  |
 Single | 19 |  |  |  |  |
Region of recurrent nodes | |||||
 Multiple | 25 | 1.104 | .293 |  |  |
 Single | 58 |  |  |  |  |
Lymph node recurrence site | |||||
 Supraclavicular | 6 | 4.586 | .101 |  |  |
 Mediastinal | 50 |  |  | 1.839(.430–7.856) | .411 |
 Abdominal | 2 |  |  | 3.123 (.262–37.160) | .367 |
Salvage Treatments | |||||
 RT | 41 | .322 | .570 |  |  |
 CCRTb | 35 |  |  |  |  |
Radiation technique | |||||
 VAMTc | 74 | .248 | .618 |  |  |
 3DCRTd | 9 |  |  |  |  |
Concurrent chemotherapy regimen | |||||
 platinum | 18 | .801 | .371 |  |  |
 fluorouracil | 15 |  |  |  |  |
Radiation dose | |||||
 ≥ 60Gy | 46 | .020 | .888 |  |  |
 <60Gy | 37 |  |  |  |  |
Tumor Response | |||||
 CR + PR | 68 | .331 | .565 |  |  |
 SD + PD | 15 |  |  |  |  |